- Home
- CELC vs BLKB Comparison
CELC vs BLKB Comparison
Compare CELC & BLKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | BLKB |
|---|---|---|
| Founded | 2011 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.7B |
| IPO Year | 2017 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CELC | BLKB |
|---|---|---|
| Price | $100.40 | $62.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | ★ $100.13 | $70.50 |
| AVG Volume (30 Days) | ★ 959.5K | 353.7K |
| Earning Date | 11-12-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,136,093,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.09 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.58 | $54.56 |
| 52 Week High | $112.64 | $81.63 |
Technical Indicators
Market Signals| Indicator | CELC | BLKB |
|---|---|---|
| Relative Strength Index (RSI) | 59.08 | 56.22 |
| Support Level | $100.00 | $60.62 |
| Resistance Level | $112.64 | $63.59 |
| Average True Range (ATR) | 5.00 | 1.95 |
| MACD | -1.28 | 0.49 |
| Stochastic Oscillator | 21.82 | 75.32 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About BLKB Blackbaud Inc.
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.